newdrugapprovals.org
PHASE 1-BMS-906024 by Bristol-Myers Squibb to treat breast, lung, and colon cancers and leukemia
BMS-906024 is in Phase I clinical trials, both alone and in combination with other agents. Patients with colon, lung, breast, and other cancers are receiving intravenous doses of the compound to de…